Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

Presentation TCT 2016

Endovascular Intervention I: Aorta, Renal, Iliac, Femoropopliteal

Presenter: Kenneth Rosenfield, Sahil A. Parikh

October 31, 2016

Presentation TCT 2016

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

Presenter: Sriram S. Iyer, Craig M. Walker, Daniel Ortiz

October 31, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Industry News

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

September 15, 2016

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

News Industry News

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

April 26, 2016

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

Presentation VEINS 2014

DEBATE: Treatment of Femoropopliteal DVT - No, We Must Consider Aggressive Measures

Presenter: Mark J. Garcia

October 10, 2014

Presentation TCT 2014

Excimer Laser for Femoropopliteal In-Stent Restenosis: Light at the End of the Tunnel?

Presenter: John R. Laird Jr, Daniel J. McCormick, Dmitriy N. Feldman, Carlos I. Mena-Hurtado

September 13, 2014

News Daily News

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Yael L. Maxwell

April 26, 2013

Presentation TCT 2012

Femoropopliteal Atherectomy: A Critical Appraisal

Presenter: Lawrence Garcia

October 24, 2012

Advertisement

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

Endovascular Intervention I: Aorta, Renal, Iliac, Femoropopliteal

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

DEBATE: Treatment of Femoropopliteal DVT - No, We Must Consider Aggressive Measures

Excimer Laser for Femoropopliteal In-Stent Restenosis: Light at the End of the Tunnel?

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Femoropopliteal Atherectomy: A Critical Appraisal

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content